Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHO: Colchicine for Prevention of Joint Replacement in Osteoarthritis
NCT06578182Phase 3Recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Jan 2025
- Primary completion
- Mar 2029
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in osteoarthritis (OA), sponsored by Sint Maartenskliniek. Started Jan 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06578182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06578182.